RETN and chronic kidney disease: After conducting this study with CKD patients and participants without a kidney function decrease, we may conclude that resistin concentrations rise not only with the progression of kidney function decrease and with the fall of eGFR, but also with the increase of CV risk in CKD; thus, resistin may contribute to the progression of cardiovascular risk in this group of patients.